Akston Biosciences Corporation logo

Akston Biosciences Corporation

Akston Biosciences Corporation is Beverly based biopharma company developing therapeutics for the treatment of Alzheimers disease.

Akston Biosciences was founded by Dr. Zion doctorate in Chemical Engineering at the Massachusetts Institute of Technology, they targeting disease-causing biomolecules for site-directed elimination.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.akstonbio.com
Founded2011
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
100 Cummings Center, Ste 454C, Beverly, 01915,
Massachusetts
United States
Email
Contact Number
+1 978-969-3381

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/akston-biosciences-corporation” connections=”true” suffix=””]

In June 2014, Akston was awarded a $249,926 NIH Phase I SBIR grant to support its work in identifying, compounds for reducing brain A-Beta levels via Enhanced Systemic Clearance.